2[1]Ross SD,Allen IE,Connelly JE et al.Clinical outcomes in statin treatment trials:a meta-analysis.Arch Intern Med,1999;159(15):1793～1802
3[2]Larosa JC,He J,Vupputuri S.Effect of Statin on risk of coronary disease:a meta-analysis of randomized controlled trials.JAMA,1999;284(24):2340～2346
4[3]Sacks FM,Tonkin AM,Shepherd J et al.Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors.Circulation,2000;102(16):1893～1900
5[4]Stenestrand U,Wallentin L.Early statin treatment following acute myocardial infarction and 1 year survival.JAMA,2001;285(4):430～436
6[5]Dimascio R,Marchioli R,Tognonic G.Cholesterol reduction and stroke occurrence:an overview of randomized clinical trials.Cerebrovasc Dis,2000;10(2):85～92
7[6]Plehn JF,Davis BR,Sacks FM et al.Reduction of stroke incidence after myocardial infarction with pravastatin:the cholesterol and Recurrent Events(CARE) study.Circulation,1999;99(2):216～223
8[7]Rosenson RS.Biological basis for statin therapy in stroke prevention.Curr Opin Neurol,2000;13(1):57～62
9[8]Spostito AC,Mansur AP,Coelho OR et al.Addition reduction in blood pressure after cholesterol-lowering treatment by statins in hypercholesterolemic patients using angiotenisn converting enzyme inhibitors.Am J Cardiol,1999;83(10):1497～1499
10[9]Borghi C,Prandin MG,Costa FV et al.Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.J Cardiovasc pharmacol,2000;35(4):549～555
